Global Technology Report

Neurostimulation Devices Market to exceed $13bn by 2023

Germany and UK combinedly accounted for nearly 35% of overall regional revenue share in 2015. Healthcare industry development coupled with increase in consumer affordability have positively inclined Europe neurostimulation devices market growth.
Neurostimulation Devices Market Size By Product (Deep Brain Stimulator, Gastric Electric Stimulator, Spinal Cord Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator), By Application (Pain Management, Epilepsy, Essential Tremor, Urinary and Fecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson’s Disease), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2016 – 2023

Rising incidences of neurological disorders among the geriatric population will influence neurostimulation devices industry growth. In addition, increasing demands for suitable, cost-effective treatment options, high-tech healthcare facilities, and technologically-driven infrastructure will drive product demand. According to Global Market Insights, Inc., “Neurostimulation Devices Market is predicted to observe a CAGR of more than 14% over 2016-2023.”

Federal guidelines and lack of skilled professionals in the healthcare fraternity may hamper industry growth. However, global incidences of conditions such as epilepsy, migraine, depression, and other neurological ailments are on a constant rise, driving the requirement for positive therapeutic effects of neuro-stimulators.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/436

Neurostimulation Devices find applications in the treatment of Parkinson’s Disease, Epilepsy Pain Management, Essential Tremor, Urinary and Fecal Incontinence, Gastroparesis Depression, and Dystonia.

Neurostimulation devices market size for pain management will register a revenue of more than USD 9 billion by 2023 and is expected to grow at a healthy rate owing to the high prevalence of chronic disorders.

                         Germany Neurostimulation Devices Market size, by product, 2012-2023 (USD Million)

                             Germany Neurostimulation Devices Market size, by product, 2012-2023 (USD Million)

Therapeutic applications for Parkinson’s disease will increase at a high rate over 2016-2023 driven by the increasing elderly population and limited treatment options.

The epilepsy application segment is predicted to exceed USD 600 million by 2023 driven by product efficiency and less availability of suitable treatment.

Request for a sample of this research report @ https://www.gminsights.com/inquiry-before-buying/436

Tremors are commonly faced by people above the age of 40 and can be treated using implantable deep brain stimulators. Rising frequency of tremors and convenient FDA regulations for their treatment will help propel the market further.

Regional trends influencing neurostimulation devices industry growth:

  • China neurostimulation devices market is forecast to attain heavy gains at 18.0% over 2016-2023, driven by developing healthcare facilities and growing awareness regarding neurological disorders.
  • U.S. neurostimulation devices industry size was worth more than USD 2 billion in 2015 and is set to cross USD 5.5 billion by 2023, driven by high-tech medical infrastructure, excellent healthcare facilities, and growing patient awareness. Organizations such as the American Tinnitus Association and the North American Neuromodulation Society will help fuel regional growth.
  • Latin America neurostimulation devices market, dominated by Brazil and Mexico, contributed to around 4% of the overall share in 2015, and is likely to grow at a significant rate, which can be attributed to changing lifestyle, increasingly disposable incomes, developing healthcare facilities, and a huge number of patients.
  • Europe neurostimulation devices industry is set to register healthy gains, owing to contributing factors such as growing elderly population, government approval and encouragement, and rapid economic growth.

Neurostimulation devices market is segmented into products such as sacral nerve stimulator, gastric electric stimulator, deep brain stimulator, spinal cord stimulator, and vagus nerve stimulator.

Sacral nerve neurostimulation devices industry is expected to increase at a CAGR of more than 19% driven by the rising demand for incontinence products.

Spinal cord neurostimulation devices market is targeted to register around USD 6.5 billion by 2023, owing to the increasing recurrence of peripheral vascular disease, failed-back surgery syndrome, refractory angina pectoris, and complex regional pain syndrome.

Vagus nerve and gastric electric neurostimulation devices industry is anticipated to grow at a stable rate over 2016-2023.

Browse key industry insights spread across 95 pages with 72 market data tables & 6 figures & charts from the report Neurostimulation Devices Market in detail along with the table of contents:

https://www.gminsights.com/industry-analysis/neurostimulation-devices-market-report

Deep brain neurostimulation devices market is expected to depict profitable gains in the coming years and will grow at a CAGR of more than 17% over 2016-2023, driven by the requirement of treatment options for disorders such as dementia, depression, Parkinson’s, and obsessive compulsive disorders.

Key industry participants in this market include Cyberonics Inc., Nevro, Medtronic, Neuronetics, and Boston Scientific. Other vital companies are IntraPace, Codman & Shurtleff Inc., and St. Jude Medical. Companies are rigorously involved in R&D activities to develop sophisticated technologies and highly innovative products, owing to the fact that this industry is still nascent.

An ever-growing geriatric population falling prey to disorders such as Parkinson’s and Alzheimer’s will fuel product demand. The implementation of advanced technological developments such as transdermal neuromodulation technology and MRI safety-enabled devices to develop suitable treatment solutions for obesity, migraine, sleep apnea, and related ailments will contribute toward neurostimulation devices industry expansion.

 

Browse Related Reports:

  • Craniomaxillofacial Devices Market Size By Product [Cranial Flap Fixation, CMF Distraction, Temporomandibular Joint Replacement, Thorasic Fixation, Bone Graft Substitute, MF Plate and Screw Fixation], By Material [Metal, Bioabsorbable Material, Ceramic], By Application [Neurosurgery & ENT, Orthognathic and Dental Surgery, Plastic Surgery], Industry Analysis Report, Regional Outlook (U.S., Canada, Germany UK, China, Japan, India, Mexico, Brazil, South Africa), Application Potential, Price Trend, Competitive Market Share & Forecast, 2016 – 2023

        https://www.gminsights.com/industry-analysis/craniomaxillofacial-devices-market

 

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Media Contact
Company Name: Global Market Insights Inc.
Contact Person: Arun Hegde
Email: Send Email
Phone: 1 302-846-7766
Address:29L Atlantic Avenue, Suite L 105
City: Ocean View
State: Delaware
Country: United States
Website: https://www.gminsights.com/industry-analysis/neurostimulation-devices-market-report

About Author

editor

editor